The immunosuppressant drug cyclosporin A (CsA) inhibits
T-cell function by blocking the phosphatase activity of
calcineurin. This effect is mediated by formation of a
complex between the drug and cyclophilin (CyP), which creates
a composite surface able to make high-affinity contacts
with calcineurin. In vitro, the CyPB/CsA complex is more
effective in inhibiting calcineurin than the CyPA/CsA and
CyPC/CsA complexes, pointing to fine structural differences
in the calcineurin-binding region. To delineate the calcineurin-binding
region of CyPB, we mutated several amino acids, located
in two loops corresponding to CyPA regions known to be
involved, as follows: R76A, G77H, D155R, and D158R. Compared
to wild-type CyPB, the G77H, D155R, and D158R mutants had
intact isomerase and CsA-binding activities, indicating
that no major conformational changes had taken place. When
complexed to CsA, they all displayed only reduced affinity
for calcineurin and much decreased inhibition of calcineurin
phosphatase activity. These results strongly suggest that
the three amino acids G77, D155, and D158 are directly
involved in the interaction of CyPB/CsA with calcineurin,
in agreement with their exposed position. The G77, D155,
and D158 residues are not maintained in CyPA and might
therefore account for the higher affinity of the CyPB/CsA
complex for calcineurin.